Previous studies with the bulbs of Cipura paludosa (Iridaceae) showed the presence of pyranonaphthoquinones, including eleutherine, isoeleutherine and eleutherol. The aim of this study was to evaluate the antifungal properties of these compounds. The activity was tested against the clinically relevant yeasts Candida albicans, C. tropicalis, Saccharomyces cerevisiae and Cryptococcus neoformans with the microbroth dilution method, following the guidelines of CLSI. Eleutherine, isoeleutherine and eleutherol all presented significant antifungal activity, especially the first two, the major components, with MIC values between 7.8 and 250 μg/mL. In conclusion, these results demonstrate that C. paludosa bulbs produce active principles with relevant antifungal potential, contributing, at least in part, to the antimicrobial effect evidenced for this plant and justifying its popular use against infections.
NegriM., SalciT.P., Shinobu-MesquitaC.S., CapociI.R.G., SvidzinskiT.I.E., KioshimaE.S. (2014) Early state research on antifungal natural products. Molecules, 19, 2925–2956.
2.
TesseleP.B., Delle MonacheF., QuintãoN.L.M., Da SilvaG.F., RochaL.W., LucenaG.M., FerreiraV.M., PredigerR.D., Cechinel-FilhoV. (2011) A new naphthoquinone isolated from the bulbs of Cipura paludosa and pharmacological activity of two main constituents. Planta Medica, 77, 1035–1043.
3.
LucenaG.M., GadottiV.M., MaffiL.C., SilvaG.S., AzevedoM.S., SantosA.R. (2007) Antinociceptive and anti-inflammatory properties from the bulbs of Cipura paludosa Aubl. Journal of Ethnopharmacology, 112, 19–25.
4.
LucenaG.M., PortoF.A., CamposE.G., AzevedoM.S., Cechinel-FilhoV., PredigerR.D., FerreiraV.M. (2010) Cipura paludosa attenuates long-term behavioral deficits in rats exposed to methylmercury during early development. Ecotoxicology and Environmental Safety, 73, 1150–1158.
5.
LucenaG.M., MatheusF.C., FerreiraV.M., TesseleP.B., AzevedoM.S., Cechinel-FilhoV., PredigerR.D. (2013) Effects of ethanolic extract and naphthoquinones obtained from the bulbs of Cipura paludosa on short-term and long-term memory: Involvement of adenosine A1 and A2A receptors. Basic & Clinical Pharmacology & Toxicology, 112, 229–235.
6.
VicenteM.F., BasilioA., CabelloA., PeláezF. (2003) Microbial natural products as a source of antifungals. Clinical Microbiology and Infection, 9, 15–32.
7.
ChenS., PlayfordE., SorrelT. (2010) Antifungal therapy in invasive fungal infections. Current Opinion in Pharmacology, 10, 522–530.
8.
CarrascoH., RaimondiM., SvetazL., Di LibertoM., RodriguezM.V., EspinozaL., MadridA., ZacchinoS. (2012) Antifungal activity of eugenol analogues. Influence of different substituents and studies on mechanism of action. Molecules, 19, 1002–1024.
9.
ParkB.J., WannemuehlerK.A., MarstonB.J., GovenderN., PappasP.G., ChillerT.M. (2009) Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS, 23, 525–530.
10.
AlspaughJ.A. (2015) Virulence mechanisms and Cryptococcus neoformans pathogenesis. Fungal Genetics and Biology, 78, 55–58.
11.
AzevedoM.I., FerreiroL., Da SilvaA.S., ToninA.A., RuchelJ.B., RezerJ.F., FrançaR.T., ZimmermannC.E., LealD.B., DuarteM.M., LopesS.T., FloresM.M., FigheraR., SanturioJ.M. (2014) E-NTPDase and E-ADA activities in rats experimentally infected by Cryptococcus neoformans. Veterinary Microbiology, 174, 206–213.
12.
VuK., ThamR., UhrigJ.P., ThompsonG.R.III, Na PombejraS., JamklangM., BautosJ.M., GelliA. (2014) Invasion of the central nervous system by Cryptococcus neoformans requires a secreted fungal metalloprotease. MBio, 5, 01101–14.
13.
SasakiK., AbeH., YoshizakiF. (2002) In vitro antifungal activity of naphthoquinone derivatives. Biological and Pharmaceutical Bulletin, 25, 669–670.
14.
AlvesT.M.A., KloosH., ZaniC.L. (2003) Eleutherinone, a novel fungitoxic naphthoquinone from Eleutherine bulbosa (Iridaceae). Memórias do Instituto Oswaldo Cruz, 98, 709–712.
15.
FerreiraV.F., FerreiraS.B., da SilvaF.D.C. (2010) Strategies for the synthesis of bioactive pyran naphthoquinones. Organic & Biomolecular Chemistry, 8, 4793–4802.
16.
RahmounN.M., Boucherit-OtmaniZ., BoucheritK., BenabdallahM., VilleminD., Choukchou-BrahamN. (2012) Antibacterial and antifungal activity of lawsone and novel naphthoquinone derivatives. Médecine et Maladies Infectieuses, 42, 270–275.
17.
FerreiraMpsbc, CardosoM.F.C., da SilvaF.C., FerreiraV.F., LimaE.S., SouzaJ.V.B. (2014) Antifungal activity of synthetic naphthoquinones against dermatophytes and opportunistic fungi: preliminary mechanism-of-action tests. Annals of Clinical Microbiology and Antimicrobials, 6, 13–26.
18.
HookI., MillsC., SheridanH. (2014) Bioactive naphthoquinones from higher plants. Studies in Natural Products Chemistry, 41, 119–160.
19.
XuJ., QiuF., QuG., WangN., YaoX. (2005) Studies on antifungal constituents isolated from Eleutherine americana. Zhongguo Yaowu Huaxue Zazhi, 15, 157–61.
20.
KusumaI.Y., ArungE.T., RosamahE., PurwatiningsihH., AstutiJ., KimY.U., ShimizuK. (2010) Antidermatophyte and antimelanogenesis compound from Eleutherine americana grown in Indonesia. Journal of Natural Medicines, 64, 223–226.
21.
CLSI - Clinical and Laboratory Standards Institute. (2008) Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard-3rd ed. CLSI Document M27-A3; CLSI: Wayne, PA, USA, 28(14), 1–25.
